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Abstract
Chronic periodontitis and chronic obstructive pulmonary disease (COPD) are chronic 
inflammatory diseases in which neutrophilic inflammation plays a major role. There are 
a few studies showing that these two entities share various predisposing factors and 
pathogenetic mechanisms; however, a direct connection between them has not yet been 
achieved. Epidemiology data may also show a connection between the two conditions. 
Neutrophilic inflammation in periodontitis and COPD is orchestrated by CD8+ lympho‐
cytes and macrophages, leading to the aggregation of neutrophils and causing an imbal‐
ance to the proteases and antiproteases equilibrium. Finally, further research is needed 
to clarify the common pathogenesis of the two diseases to optimize their therapeutic 
management.
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1. Introduction
Periodontitis is a chronic inflammatory disease of the oral cavity, affecting the structures 
that support the teeth. Almost half of the adult population has a great inflammation of 
the gums that causes loss of optimal contact between the teeth and periodontal tissues 
[1]. About 11% of adults develop clinical periodontitis. The dental plaque is caused by the 
development of anaerobic bacteria that cause accumulation and activation of neutrophils, 
which is orchestrated by various mediators and enzymes that destroy the connective tissue 
[2, 3]. Untreated periodontitis ultimately leads to loss of support of the teeth, and atrophy 
of the alveolar process, causing loss of the teeth.
© 2017 The Author(s). Licensee InTech. This chapt r is distributed under the terms of the Creative Comm s
Attribution L cense (http://creativecommons. /licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder of the air‐
ways, largely caused by smoking, and it is characterized by progressive and partially 
reversible airflow limitation [4]. The airflow obstruction and consequently the disease are 
confirmed by the presence of a postbronchodilator FEV1/FVC < 0.70 [5]. The disease con‐
stitutes one of the leading causes of morbidity and mortality in the industrialized world, 
affecting approximately 210 million people worldwide. In 2004, COPD was the fourth 
most common cause of death and it is expected to be the third cause of mortality by 2030 
[6, 7].
COPD is a combination of chronic bronchitis and emphysema, and as a result, it constitutes 
a heterogeneous disease. The most common symptoms in patients suffering from COPD are 
dyspnea, cough, and production of sputum, which are chronic and progressive [8].
The lesions present in COPD and periodontitis are linked to various immunologic mecha‐
nisms, in which T‐lymphocytes, macrophages, and neutrophils have a major role. Our chap‐
ter attempts to analyze the similarities in pathophysiology of COPD and chronic periodontitis 
and to elucidate the common pathogenetic mechanisms.
2. The role of chronic inflammation
COPD and chronic periodontitis are characterized by chronic neutrophilic inflammation, 
which mainly stems from the activity of enzymes released from granules of neutrophils. It is 
known that the development of COPD depends on the variable exposure to harmful factors, 
such as cigarette smoking, as well as on the susceptibility of the individual [9]. It is estimated 
that only a percentage of smokers (5–20%) develop COPD. Moreover, some patients develop 
mild disease, others moderate, and others serious disease. Among COPD patients, 80–90% 
have been current or ex‐smokers. Air pollution and occupational exposure have also been 
responsible for some COPD cases at a lower rate.
On the other hand, in periodontitis, there is an interaction between environmental and 
genetic factors, which eventually leads to the development of the disease. In both COPD and 
periodontitis, the pathophysiological mechanisms include the accumulation and activation of 
neutrophils. Factors secreted by neutrophil granules cause damage to the connective tissue 
[10].
It is believed that COPD is a condition of chronic systemic inflammation, characterized by 
elevated C‐reactive protein (CRP), interleukin‐8 (IL‐8), and tumor necrosis factor‐α (TNF‐α), 
whose levels determine the severity of disease, which is in line with the degree of muscle 
atrophy and dysfunction. These cytokines are also related to the development of coronary 
artery disease and diabetes [11]. Morbidity and mortality also depend on social and economic 
factors [12].
Inflammatory responses taking place in periodontitis are usually caused by the presence of 
anaerobic microbes. Thus, the levels of pro‐inflammatory cytokines, such as CRP and TNF‐α, 
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are remarkably elevated. In both COPD and periodontitis, there is an increased incidence of 
heart attack, osteoporosis, diabetes mellitus and rheumatoid arthritis as a result of chronic 
inflammation [13].
3. Epidemiology of COPD and periodontitis
A variety of stimuli can induce the development of COPD, including heritable genes in con‐
junction with environmental risk factors. Air pollutants, cold temperature, lack of compliance 
with respiratory medication, and other noninfectious causes, as well as infections, are the 
usual triggers of acute exacerbations of COPD. Infections, which are the most frequent cause 
of exacerbations, could be of either bacterial or viral etiology [14]. It is known that almost half 
of the infections are caused by bacteria, while viruses are responsible for almost the rest of 
the infections. Moreover, coinfection with bacteria and viruses is identified in patients with 
severe COPD.
Smoking is an important predisposing factor both in COPD and in periodontitis. Almost 80% 
of COPD patients are current or ex‐smokers. COPD is also associated with age, impaired lung 
function, and gender. Initially, it was believed that the impact was greater in men, but more 
recent data exhibit equal or greater sensitivity of women smokers to develop COPD [15].
A working environment involving exposure to dust and harmful gases increases the risk of 
developing the disease. When smoking coexists, there is a sixfold risk. Exposure to inhaled 
gases from burning biomass increases the risk. There are not causative microbes causing 
COPD to develop. However, several viruses and bacteria are responsible for COPD disease 
exacerbations that lead to impaired lung function and quality of life deterioration [16].
Smoking is also a risk factor for the development of periodontitis, and the severity of the disease 
depends on the density of smoking habit [17]. Men and elderly people are more susceptible for 
COPD and periodontitis. Other predisposing factors include diabetes and poor socioeconomic 
conditions. Since 1990, there has been an increasing interest in the possible links between COPD 
and periodontitis. There is a correlation between poor oral hygiene and COPD [18].
In a study of military veterans, a diagnosis of COPD was made in subjects with an FEV1/FVC 
ratio < 70% and a history of smoking. The existence of periodontitis was documented by X‐ray 
results which show the loss of the alveolar bone. It was observed that a loss of 20% of the 
alveolar bone leads to an increased risk for development of COPD by 60%. However, it should 
be noted that the reduction of FEV1 is related not only to the existence of COPD but also to 
other respiratory diseases [19].
Other notable studies attempt to correlate COPD severity with the existence of periodontitis 
using more comprehensive definitions for the existence of COPD. In a study of 600 people with 
COPD was shown that the risk of developing COPD was associated directly with the quality of 
oral hygiene [20]. More specifically, patients with COPD had a higher dental plaque index, and 
an insufficient support of the tooth from the surrounding tissues. Moreover, the same patients 
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had an unsatisfactory behavior regarding their oral hygiene, as measured by the frequency of 
toothbrushing, the use of dental yarns, and the frequency of visits to the dentist [21]. In another 
study, a direct correlation between COPD severity and poor hygiene was found in general. 
Therefore, this observation implies that the possibility of poor oral hygiene and the unfavorable 
course of COPD may be linked to nonhealthy lifestyle and poor socioeconomic conditions [22].
It is known that the pathogenesis of COPD is directly associated with the pathological relation‐
ship of proteases/antiproteases in the lung. The same theory has been suggested in periodon‐
titis. Past studies have shown that in patients suffering from mild COPD and periodontitis the 
levels of metalloproteinase‐8 (MMP‐8) are elevated in saliva and serum. MMP‐8 is a product 
of the secretion of neutrophils. However, levels of MMP‐8 in saliva showed no statistically sig‐
nificant difference in patients with mild COPD who had no periodontitis compared to those 
that did not suffer from COPD. Some other studies demonstrate a poor correlation between 
COPD and periodontitis [23].
To sum up, several meta‐analyses have shown that periodontitis increases the risk of develop‐
ing COPD; however, the exact mechanism is still not fully understood. Future studies should 
focus on the elucidation of such pathogenetic mechanisms.
4. Pathophysiology of COPD and periodontitis
COPD is characterized by limitation of airflow which is partially reversible. Progressive 
decline of FEV1, inadequate lung emptying on expiration, and static and dynamic hyperinfla‐
tion are the results of remodeling of the small‐airway compartment and loss of elastic recoil 
by emphysematous destruction of parenchyma [24]. Exposure to smoke leads to infiltration 
of the mucosa, submucosa, and glandular tissue by inflammation cells. Increased mucus con‐
tent, epithelial‐cell hyperplasia, and disturbed tissue repair with wall thickening in the small 
conducting airways are the main features of COPD [25].
Smoking can cause injury of airway epithelial cells, and as a result, endogenous signals are 
released and recognized by receptors such as Toll‐like receptors 4 and 2 on epithelial cells. 
This recognition leads to a nonspecific inflammatory response which involves the release of 
early cytokines, macrophages, neutrophils, and dendritic cells and the transportation of these 
features to the site of inflammation [26]. Self‐antigens released from damaged tissue as well as 
foreign antigens from incoming pathogens are presented to naïve T‐cells by dendritic cells. The 
T‐cells are activated into T‐helper‐1 cells, and these specific CD4 and CD8 cells as well as B‐cells 
which produce antibodies are transferred to the lungs so as to neutralize the antigens [27].
Alveolar macrophages and other immune cells produce proteinases that destroy the basal mem‐
brane and also cause damage to the collagen and elastic fibers of the connective tissue, leading 
to the development of emphysema [28]. Moreover, they secrete IL‐4 and IL‐3 that cause edema 
and increased production of mucus, which are both associated with airway hyperresponsive‐
ness. These responses take place at the respiratory lobule of second order that is located after 
the terminal bronchiole. It consists of 3–5 generations of respiratory bronchioles that contain 
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alveoli. This is the structure that is responsible for the exchange of respiratory gases, and its 
destruction may cause impaired gas exchange and respiratory failure [29]. Moreover, apart 
from the lack of α‐1 antitrypsin, other genetic factors involved in the pathogenesis of the dis‐
ease include interleukins and cysteine proteinases and elastases, which orchestrate an immune 
response which can lead to the destruction of the pulmonary parenchyma. Mast cells play an 
important role as antigen‐presenting cells in the lung as well, and they have been shown to be 
valuable both in COPD and in periodontitis.
Smoking is the main factor that initiates immune system reaction in chronic inflammatory 
diseases as the chronic obstructive pulmonary disease and periodontitis [30]. In response to 
smoking, neutrophils accumulate rapidly in the lung, because the macrophages and epithelial 
cells of the lung are activated. They secrete neutrophil‐attracting factors such as IL‐8, C5a, and 
LTB4. The stimulation of neutrophils causes oxidative damage to the lung due to oxygen radi‐
cals produced by activated neutrophils. Moreover, free oxygen radicals cause oxidative injury 
to the lung [31]. Oxygen radicals play a role in premature cellular death, but also act on the 
epithelial and mesenchymal cells. The destruction of the cellular matrix causes a destruction of 
the supporting connective tissue. Some of these polypeptides as laminin and fibronectin have 
chemotactic effect and attract neutrophils, playing a key role in the sequence of events of the 
destruction of lung parenchyma due to smoking. Neutrophils contain proteinases stored in 
their granules, which are released and destroy the parenchyma. There are metalloproteinase‐9 
(MMP‐9) and serine proteinases, which are released and destroy elastin. Elastin is the charac‐
teristic component of elastic fibers, which determine the elastic properties of the lung paren‐
chyma. The destruction of the elastic fibers causes an increased lung compliance and reduction 
of elasticity, which are characteristic changes in pulmonary emphysema [32]. Elastin segments 
act as chemotactic agents for macrophages. The aggregated macrophages secrete metallopro‐
teinases in turn and participate in the destruction of lung parenchyma. Macrophages secrete 
chemokines, which maintain the chronic inflammation that characterizes COPD (Figure 1) [33].
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Figure 1. Pathogenetic mechanisms of lung destruction in COPD.
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Apart from neutrophils and macrophages, there are also increased numbers of CD4+ T lym‐
phocytes and CD8+ T lymphocytes in bronchioles and alveoli of COPD patients. Epithelial cells 
of smokers with COPD show an increased expression of CXC40 factor, which is a structural 
element of the agent of T‐cell, CXRCR3 [34]. Although the precise role of T cells is not fully 
understood, it seems that they produce metalloproteinases, which have profound destructive 
effects on pulmonary parenchyma. The cytotoxic T‐cells are also likely to affect epithelial 
cells, leading to premature cellular death. Other cells, such as dendritic cells and eosinophils, 
have also been reported to be increased in COPD. But their exact role is still unknown.
Cigarette smoking, as previously explained, is the main factor to initiate chronic inflammation. 
However, a few other factors cause inflammation to perpetuate, even years after smoking ces‐
sation. Indeed, in histological lung preparations derived from pneumonectomy, inflammation 
cells, such as macrophages, T‐cells, neutrophils, and eosinophils are observed, even 9 years 
after the end of smoking habit [35]. The exact mechanism of persistent inflammation is not 
known, but it seems that the impaired mobility of the cilia of epithelial cells of the respiratory 
mucosa predisposes to the colonization of airways with bacteria, which in turn predisposes to 
viral infections, especially adenovirus infections, which trigger the inflammatory processes. 
Despite the controversial pathogenesis, numerous inflammatory cells participate in COPD 
pathogenesis and cause inflammation that proceeds even when the original trigger of cigarette 
smoke is absent.
These pathogenetic mechanisms have not yet been confirmed in the case of periodonti‐
tis. It is known that neutrophils are the inflammatory cells that predominate in cases of 
gingivitis [36] and their role in the pathogenesis of chronic periodontitis has been inves‐
tigated. But, it is not yet fully understood whether the neutrophils have the same charac‐
teristics and the same role in both periodontitis and COPD. Further research is needed 
in the field. However, it is known that in both COPD and periodontitis, activated neu‐
trophils secrete inflammatory mediators, such as proteinases and oxygen radicals, which 
are involved in tissue damage and in chronic inflammation. This is an important feature 
of both conditions. Moreover, increased free radicals are produced when cells are exog‐
enously stimulated by the means of Fusobacterium nucleatum, a bacterium that frequently 
causes periodontitis [37].
It should be noted that adverse effects are also caused when local levels of antioxidant factors 
in interstitial fluid gum are disrupted. At this point, we should remark that if the hypothesis 
of diffuse inflammation is adopted, we can assume that successful treatment of one disease 
(periodontitis) could improve the other (COPD) and conversely. It is known that there is a 
positive correlation between poor oral hygiene and the frequency of COPD exacerbations 
[38]. In a recent study, patients with COPD and concomitant periodontitis were tested. Half 
of them (20 patients) received proper treatment for periodontitis, while the rest 20 patients 
did not receive any treatment at all. They were all observed for 12 months, and it was 
reported that in the first group a lower frequency of COPD exacerbations was documented. 
Although this is a significant finding, the study had some methodological problems such 
as the fact that the selection of patients was not randomized and the sample size was small. 
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Nevertheless, the findings of this study should be carefully considered in order to carry out 
further investigation in the field.
5. Antibiotic treatment in chronic periodontitis and COPD
Exacerbations are short periods in the course of COPD characterized by increased cough, 
dyspnea, and production of sputum that can become purulent. They can lead to accelerated 
lung function impairment, worse quality of life, and increased mortality [39]. Except from the 
severity, the frequency of the exacerbations, also, plays an important role in the management 
of the exacerbations. Depending on the severity of the exacerbation, different therapeutic 
strategies could be used. Therefore, increased doses of bronchodilators are required for mild 
exacerbations, systemic corticosteroids, and antibiotics can be used for moderate exacerba‐
tions, whereas severe exacerbations often require admission to hospital [40]. However, the 
most frequent causes of exacerbations are bacterial or viral infections, which are responsible 
for 60–80% of all exacerbations. These infectious exacerbations are more severe than the non‐
infectious exacerbations.
There are some articles concerning the possible relationship between chronic inflammatory 
diseases and their comorbidities. Both chronic periodontitis and COPD are neutrophilic, 
inflammatory conditions characterized by loss of local connective tissue. It is possible that 
there is an association and perhaps a casual link between the two diseases. It has been reported 
that respiratory pathogens such as Pseudomonas aeruginosa might adhere better to oral epithe‐
lial cells obtained from patients colonized by respiratory pathogens than to cells harvested 
from noncolonized patients. Trypsin treatment of epithelial cells from noncolonized patients 
in vitro resulted in increased adhesion of respiratory pathogens [41]. This suggests that muco‐
sal alteration promoted enhanced bacterial adhesion of these bacteria. This alteration is per‐
haps the loss of fibronectin (by exposure to proteases) from the epithelial cell surface, which 
may unmask mucosal surface receptors for respiratory pathogen adhesions.
Subjects with poor hygiene may have elevated levels of hydrolytic enzymes in their saliva. 
These enzymes may process mucins to reduce their ability to bind to and clear pathogens 
such as Haemophilus influenzae. Conversely, the enzymes may process the respiratory epithe‐
lium to modulate the adhesion of such pathogens to the mucosal surface. Mannino et al. [42] 
postulated that oral pathogens continuously stimulate the cells of the periodontium (epithe‐
lial cells) to release a wide variety of cytokines and other biologically active molecules such 
as IL‐1a, IL‐1b, IL‐6, IL‐8, and TNF‐a. Oral bacteria in secretions may adhere to the mucosal 
surface and stimulate the epithelial cells of the respiratory epithelium to secrete cytokines. 
These stimulated cells may then release other cytokines that recruit inflammatory cells to the 
site. These inflammatory cells release hydrolytic enzymes resulting in damaged epithelium 
that may be more susceptible to colonization by respiratory pathogens. It is possible that the 
poor oral health might work in concert with other factors (smoking, environmental pollution, 
viral infections, and genetic factors) to promote the progression and exacerbation of pulmo‐
nary disease.
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6. Conclusions
The associations demonstrated between periodontitis and COPD suggest a basis for test‐
ing the effects of treatment for one condition upon the severity of the other. Improving oral 
hygiene might reduce the risk of respiratory infection among subjects who are at risk.
Our article describes similarities in epidemiology and pathogenetic mechanisms of COPD 
and periodontitis and proposes that improvement of one condition is linked to the treatment 
of the other. Future research is needed to clarify the existing pathogenetic mechanisms and 
extend possible therapeutic options.
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